Why is Jenburkt Pharma falling/rising?

As of 31-Oct, Jenburkt Pharmaceuticals Ltd. is experiencing a significant rise in its stock price, currently at 1,272.90, reflecting an increase of 120.8 or 10.49%. The stock has shown strong performance, gaining 19.37% over the last three days and outperforming its sector by 10.94% today. It reached an intraday high of Rs 1321, indicating robust trading activity despite high volatility of 6.49%. Additionally, the stock has consistently traded above its moving averages across various time frames, suggesting a positive trend. However, there has been a notable decline in investor participation, with delivery volume dropping by 49.39% compared to the five-day average, which could indicate some caution among investors.
In the broader market context, Jenburkt Pharmaceuticals has outperformed the Sensex over the past week, with a return of 18.94% compared to the benchmark's slight decline of 0.32%. While the stock has shown impressive returns over longer periods, such as 121.64% over three years and 241.58% over five years, its year-to-date performance of 4.79% lags behind the Sensex's 7.42%. This divergence highlights the stock's recent strength relative to the market, particularly in the short term, despite the overall market conditions.